ED vs NEUP · P/E 18, rev $16.92B vs rev $15.7M
Consolidated Edison Inc (ED) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2025-12-31 was $16.92B. Net income was $2.02B. Revenue was up 10.9% from 2024-12-31 to 2025-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the ED and NEUP stock pages for the full models.
Not investment advice.